Trial intelligence / Profile preview

Propofol vs Midazolam for Colonoscopy in Cirrhosis

NCT01148277Phase 4Unknown

Sponsor
Ziv Medical Center
Start
Aug 2011
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of propofol (3 arms), sponsored by Ziv Medical Center. Primary endpoint: Safety and efficacy of propofol in liver diseases at 3 hours. Status: unknown.

02

Drugs

propofol

Beyond the preview

Go deeper on NCT01148277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01148277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call